Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells.
The effects of morphine are mediated mainly through the mu opioid receptor (MOR). Expression of the MOR is up-regulated during neuronal differentiation in P19 embryonal carcinoma cells and epigenetic changes play an important role in MOR up-regulation. This study investigates the basis for differentiation-dependent alterations of MOR chromatin by studying the recruitment or dissociation of several factors to the remodeled chromatin locus. Chromatin immunoprecipitation assays were used to demonstrate the recruitment of the transcriptional activator Sp1 and the chromatin remodeling factors Brg1 and BAF155 to this promoter, as well as the dissociation of repressors [histone deacetylases, mSin3A, Brm, and methyl-CpG-binding protein 2 (MeCP2)]. Histone modifications (acetylation, induction of histone H3-lys4 methylation, and reduction of H3-lys9 methylation) were consistently detected on this promoter. Overexpression of Sp1 strongly enhanced MOR promoter activity, and the histone deacetylase inhibitor trichostatin A also increased promoter activity. In vitro DNA CpG-methylation of the promoter partially blocked binding of the Sp1 factor but induced MeCP2 binding. Coimmunoprecipitation studies also found novel evidence of an endogenous MeCP2 interaction with Sp3 but a weaker interaction with Sp1. Overall, the results suggest that during neuronal differentiation, MeCP2 and DNA methylation mediate remodeling of the MOR promoter by chromatin remodeling factors (Brg1 and BAF155) from a compacted state to a conformation allowing access for transcriptional factors. Subsequent recruitment of the activating transcription factor Sp1 to the remodeled promoter results in MOR up-regulation.
Hwang
Cheol Kyu
CK
Department of Pharmacology, University of Minnesota, 6-120 Jackson Hall, 321 Church St. S.E., Minneapolis, MN 55455, USA. hwang025@umn.edu
Kim
Chun Sung
CS
Kim
Do Kyung
DK
Law
Ping-Yee
PY
Wei
Li-Na
LN
Loh
Horace H
HH
D000818:Animals; D001483:Base Sequence; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D002843:Chromatin / Q000378:metabolism*; D047369:Chromatin Immunoprecipitation; D017931:DNA Primers; D024202:Electrophoretic Mobility Shift Assay; D051379:Mice; D009474:Neurons / Q000166:cytology / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D017450:Receptors, Opioid, mu / Q000235:genetics*; D014157:Transcription Factors / Q000378:metabolism*; D015854:Up-Regulation
D002843:Chromatin; D017931:DNA Primers; D017450:Receptors, Opioid, mu; D014157:Transcription Factors
Mol Pharmacol. 2003 Dec;64(6):1410-8
14645671
Ann N Y Acad Sci. 2007 Apr;1100:299-305
17460191
Bioessays. 2003 Dec;25(12):1192-200
14635254
Science. 2003 Oct 31;302(5646):890-3
14593184
J Neurochem. 1996 Oct;67(4):1352-9
8858915
Biochem Biophys Res Commun. 2006 May 19;343(4):1132-40
16580639
Mol Cell Biol. 2007 Jul;27(13):4720-36
17452465
Cell Mol Life Sci. 2009 Sep;66(17):2933-42
19609488
Mol Pharmacol. 2005 May;67(5):1674-83
15703380
Cell. 1992 Feb 7;68(3):561-72
1346755
Nat Genet. 2006 Sep;38(9):962-4; author reply 964-7
16940996
Cell. 1988 Dec 2;55(5):887-98
3142690
Brain Res Mol Brain Res. 1998 Mar 1;54(2):321-6
9555078
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1544-9
9037090
Histol Histopathol. 2007 Mar;22(3):311-9
17163405
Epigenetics. 2008 Mar-Apr;3(2):64-8
18437052
Cell. 2002 Mar 8;108(5):587-90
11893329
Cell. 2000 Mar 31;101(1):79-89
10778858
J Cell Mol Med. 2010 May;14(5):1113-24
19438807
EMBO J. 2002 Jul 1;21(13):3377-89
12093739
Genome Biol. 2003;4(2):206
12620113
J Neurosci. 2005 Mar 30;25(13):3350-7
15800190
Biochem Biophys Res Commun. 1997 May 19;234(2):351-7
9177274
Nat Genet. 2005 Mar;37(3):254-64
15696166
FASEB J. 2007 Dec;21(14):3963-73
17625070
Physiology (Bethesda). 2006 Dec;21:404-10
17119153
Int J Oncol. 2004 Mar;24(3):719-24
14767558
Nucleic Acids Res. 1983 Mar 11;11(5):1475-89
6828386
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9081-5
8090773
J Biol Chem. 2002 Mar 22;277(12):9780-9
11773047
J Cell Mol Med. 2009 Sep;13(9B):3591-615
19602036
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14084-9
11717463
Genes Dev. 2001 Mar 1;15(5):603-18
11238380
J Neurosci. 1998 Apr 1;18(7):2538-49
9502813
Nat Rev Mol Cell Biol. 2003 Oct;4(10):809-14
14570061
Nucleic Acids Res. 2006;34(22):6392-403
17130167
Biochim Biophys Acta. 2008 Oct;1783(10):1835-46
18657578
Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):66-74
15722796
Curr Med Chem. 2006;13(24):2909-19
17073637
Methods Enzymol. 1987;152:721-35
3309570
Mol Cell Proteomics. 2008 Aug;7(8):1517-29
18453338
Neuroscience. 1999;92(3):1143-55
10426553
J Biol Chem. 2001 Apr 20;276(16):12774-80
11278523
Gene. 1999 Oct 1;238(2):291-300
10570957
J Biol Chem. 1998 Oct 16;273(42):27678-85
9765304
Annu Rev Pharmacol Toxicol. 2000;40:389-430
10836142
Curr Opin Pharmacol. 2002 Feb;2(1):69-75
11786311
Neuron. 2007 Jul 19;55(2):201-15
17640523
Nucleic Acids Res. 2007;35(5):1501-13
17284463
J Biol Chem. 2004 May 7;279(19):19764-74
14998994
J Biol Chem. 2004 Nov 5;279(45):46464-73
15322094
Trends Neurosci. 1995 Jan;18(1):22-9
7535487
Development. 2005 Jan;132(1):105-15
15576411
Cell. 2004 Sep 3;118(5):555-66
15339661
Cancer Biol Ther. 2004 Sep;3(9):825-30
15492497
Nature. 1996 Oct 31;383(6603):819-23
8893006
J Biol Chem. 2001 Nov 23;276(47):43901-8
11572871
Brain Res Mol Brain Res. 2003 Apr 10;112(1-2):153-62
12670713
J Biol Chem. 2003 Feb 7;278(6):3742-50
12446692
J Embryol Exp Morphol. 1972 Apr;27(2):353-65
4625067
J Neurochem. 1995 Oct;65(4):1636-45
7561859
J Cell Biochem. 2005 Jun 1;95(3):466-77
15832342
Trends Endocrinol Metab. 2007 Jul;18(5):215-24
17544291
Oncogene. 2001 May 28;20(24):3007-13
11420715
Brain Res Mol Brain Res. 2002 Aug 15;104(2):184-93
12225873
Neuropharmacology. 2004;47 Suppl 1:300-11
15464146
Mol Cell Biol. 2001 Feb;21(4):1155-63
11158302
Mol Pharmacol. 2003 Oct;64(4):876-84
14500744